Covered recipient · General Payments record
AHMED M SALEEM
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$887.21
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $419.28 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Indivior Inc. | $175.17 | 17 |
| Acerta Pharma LLC | $49.98 | 2 |
| PFIZER INC. | $44.24 | 2 |
| Abbott Laboratories | $41.62 | 2 |
| Lilly USA, LLC | $36.34 | 2 |
| Novo Nordisk AS | $30.36 | 1 |
| Alkermes, Inc. | $21.63 | 1 |
| Phadia US Inc. | $19.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.82 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125365502 | CMS |
| Abbott Laboratories | $18.80 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125365504 | CMS |
| Alkermes, Inc. | $21.63 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120588876 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.06 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105445668 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.92 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105494535 | CMS |
| Indivior Inc. | $4.94 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537278 | CMS |
| Indivior Inc. | $3.09 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537280 | CMS |
| Indivior Inc. | $4.36 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537282 | CMS |
| Indivior Inc. | $4.00 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537284 | CMS |
| Indivior Inc. | $21.52 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537286 | CMS |
| Indivior Inc. | $4.85 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537288 | CMS |
| Indivior Inc. | $21.97 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537290 | CMS |
| Indivior Inc. | $5.63 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537292 | CMS |
| Indivior Inc. | $9.08 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537294 | CMS |
| Indivior Inc. | $18.18 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537296 | CMS |
| Indivior Inc. | $33.06 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537298 | CMS |
| Indivior Inc. | $6.25 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537300 | CMS |
| Indivior Inc. | $2.91 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537302 | CMS |
| Indivior Inc. | $13.21 | 11/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537304 | CMS |
| Indivior Inc. | $6.08 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537306 | CMS |
| Indivior Inc. | $6.08 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537308 | CMS |
| Indivior Inc. | $9.96 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537310 | CMS |
| Lilly USA, LLC | $21.01 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136009991 | CMS |
| Lilly USA, LLC | $15.33 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136009993 | CMS |
| Novo Nordisk Inc | $30.36 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097361621 | CMS |
| PFIZER INC. | $16.14 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131682967 | CMS |
| PFIZER INC. | $28.10 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131776625 | CMS |
| Phadia US Inc. | $19.94 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067574884 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.